153 related articles for article (PubMed ID: 37989916)
1. Assessment of arterial-phase hyperenhancement and late-phase washout of hepatocellular carcinoma-a meta-analysis of contrast-enhanced ultrasound (CEUS) with SonoVue® and Sonazoid®.
Ren J; Lu Q; Fei X; Dong Y; D Onofrio M; Sidhu PS; Dietrich CF
Eur Radiol; 2024 Jun; 34(6):3795-3812. PubMed ID: 37989916
[TBL] [Abstract][Full Text] [Related]
2. Intra-individual comparison of Sonazoid contrast-enhanced ultrasound and SonoVue contrast-enhanced ultrasound in diagnosing hepatocellular carcinoma.
Guo D; Wan W; Bai X; Wen R; Peng J; Lin P; Liao W; Huang W; Liu D; Peng Y; Kang T; Yang H; He Y
Abdom Radiol (NY); 2024 May; 49(5):1432-1443. PubMed ID: 38584190
[TBL] [Abstract][Full Text] [Related]
3. Impact of Hepatocellular Carcinoma Tumor Size on Sonazoid Contrast-Enhanced Ultrasound Enhancement Features.
Chen S; Qiu YJ; Zhang Q; Lu XY; Huang YL; Dong Y; Wang WP
Ultrasound Med Biol; 2024 Jan; 50(1):39-46. PubMed ID: 37778901
[TBL] [Abstract][Full Text] [Related]
4. Development and Comparison of Prediction Models Based on Sonovue- and Sonazoid-Enhanced Ultrasound for Pathologic Grade and Microvascular Invasion in Hepatocellular Carcinoma.
Zhang R; Li D; Chen Y; Xu W; Zhou W; Lin M; Xie X; Xu M
Ultrasound Med Biol; 2024 Mar; 50(3):414-424. PubMed ID: 38155069
[TBL] [Abstract][Full Text] [Related]
5. Contrast-Enhanced Ultrasound With Perfluorobutane for Hepatocellular Carcinoma Diagnosis: Comparison of Imaging Phases and Diagnostic Criteria.
Kang HJ; Lee JM; Yoon JH; Yoo J; Kim JH; Park J
AJR Am J Roentgenol; 2024 Feb; 222(2):e2330156. PubMed ID: 37991335
[No Abstract] [Full Text] [Related]
6. Washout appearance of hepatocellular carcinomas using standardized contrast-enhanced ultrasound (CEUS) including an extended late phase observation - Real-world data from the prospective multicentre DEGUM study.
Meitner-Schellhaas B; Jesper D; Goertz RS; Zundler S; Strobel D
Clin Hemorheol Microcirc; 2023; 84(4):413-424. PubMed ID: 37334585
[TBL] [Abstract][Full Text] [Related]
7. Perfluorobutane-enhanced ultrasonography with a Kupffer phase: improved diagnostic sensitivity for hepatocellular carcinoma.
Hwang JA; Jeong WK; Kang HJ; Lee ES; Park HJ; Lee JM
Eur Radiol; 2022 Dec; 32(12):8507-8517. PubMed ID: 35705829
[TBL] [Abstract][Full Text] [Related]
8. Head-to-head comparison of Sonazoid and SonoVue in the diagnosis of hepatocellular carcinoma for patients at high risk.
Huang J; Gao L; Li J; Yang R; Jiang Z; Liao M; Luo Y; Lu Q
Front Oncol; 2023; 13():1140277. PubMed ID: 37007159
[TBL] [Abstract][Full Text] [Related]
9. Contrast-enhanced US with Sulfur Hexafluoride and Perfluorobutane for the Diagnosis of Hepatocellular Carcinoma in Individuals with High Risk.
Kang HJ; Lee JM; Yoon JH; Lee K; Kim H; Han JK
Radiology; 2020 Oct; 297(1):108-116. PubMed ID: 32749211
[TBL] [Abstract][Full Text] [Related]
10. Contrast-enhanced ultrasound (CEUS) for differentiating between hepatocellular and cholangiocellular carcinoma.
Bohle W; Clemens PU; Heubach T; Zoller WG
Ultraschall Med; 2012 Dec; 33(7):E191-E195. PubMed ID: 22194045
[TBL] [Abstract][Full Text] [Related]
11. Can contrast enhanced ultrasound differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma?
Huang JY; Li JW; Ling WW; Li T; Luo Y; Liu JB; Lu Q
World J Gastroenterol; 2020 Jul; 26(27):3938-3951. PubMed ID: 32774068
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of contrast-enhanced ultrasound washout rate in predicting hepatocellular carcinoma differentiation.
Feng Y; Qin XC; Luo Y; Li YZ; Zhou X
Ultrasound Med Biol; 2015 Jun; 41(6):1553-60. PubMed ID: 25747937
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive Diagnosis of Hepatocellular Carcinoma on Sonazoid-Enhanced US: Value of the Kupffer Phase.
Takahashi H; Sugimoto K; Kamiyama N; Sakamaki K; Kakegawa T; Wada T; Tomita Y; Abe M; Yoshimasu Y; Takeuchi H; Itoi T
Diagnostics (Basel); 2022 Jan; 12(1):. PubMed ID: 35054309
[TBL] [Abstract][Full Text] [Related]
14. Sonazoid™ versus SonoVue
Kang HJ; Lee JM; Yoon JH; Yoo J; Choi Y; Joo I; Han JK
Korean J Radiol; 2022 Nov; 23(11):1067-1077. PubMed ID: 36196767
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of Sonazoid contrast-enhanced ultrasonography for hepatocellular carcinoma: comparison with pathological diagnosis and superparamagnetic iron oxide magnetic resonance images.
Korenaga K; Korenaga M; Furukawa M; Yamasaki T; Sakaida I
J Gastroenterol; 2009; 44(7):733-41. PubMed ID: 19387532
[TBL] [Abstract][Full Text] [Related]
16. HCCs lacking arterial phase hyperenhancement (APHE) on contrast-enhanced ultrasound (CEUS) - a diagnostic challenge. Findings from the prospective multicenter DEGUM CEUS HCC trial.
Strobel D; Agaimy A; Jesper D; Zundler S; Schellhaas B
Ultraschall Med; 2023 Dec; 44(6):606-613. PubMed ID: 36781161
[TBL] [Abstract][Full Text] [Related]
17. Value of post-vascular phase (Kupffer imaging) by contrast-enhanced ultrasonography using Sonazoid in the detection of hepatocellular carcinoma.
Goto E; Masuzaki R; Tateishi R; Kondo Y; Imamura J; Goto T; Ikeda H; Akahane M; Shiina S; Omata M; Yoshida H; Koike K
J Gastroenterol; 2012 Apr; 47(4):477-85. PubMed ID: 22200940
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of modified contrast-enhanced ultrasound Liver Imaging Reporting and Data System (CEUS LI-RADS) using Sonazoid in diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis.
Liu Q; Liu T; Liu X; Zhang F; Yang J; Cheng Y; Yang Q
Quant Imaging Med Surg; 2024 Apr; 14(4):2927-2937. PubMed ID: 38617149
[TBL] [Abstract][Full Text] [Related]
19. Characterization of hepatobiliary phase hypointense nodules without arterial phase hyperenhancement on gadoxetic acid-enhanced MRI via contrast-enhanced ultrasound using perfluorobutane.
Bae JS; Lee JY; Suh KS; Hong SK; Yoon JH; Kim YJ; Yu SJ; Lee JH; Cho EJ; Lee YB; Han JK
Abdom Radiol (NY); 2023 Jul; 48(7):2321-2330. PubMed ID: 37097451
[TBL] [Abstract][Full Text] [Related]
20. Role of Contrast-Enhanced Ultrasound as a Second-Line Diagnostic Modality in Noninvasive Diagnostic Algorithms for Hepatocellular Carcinoma.
Kang HJ; Lee JM; Yoon JH; Han JK
Korean J Radiol; 2021 Mar; 22(3):354-365. PubMed ID: 33236540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
